Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 583
Selected: 0
NCT IDTitle
NCT00465673Liposomal Doxorubicin (Lipo-Dox) in Patients With Brain Metastasis From Breast Cancer
NCT00999622Study of Blood Samples and Risk of Infection in Patients With Newly Diagnosed Malignant Supratentorial Astrocytoma
NCT03497377Evaluation of 18F-DCFPyL PSMA- Versus 18F-NaF-PET Imaging for Detection of Metastatic Prostate Cancer.
NCT06398457Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies
NCT00287872Bortezomib and Thalidomide in Treating Patients With Newly Diagnosed Stage II or Stage III Multiple Myeloma
NCT00946023Optimized Donor Selection, Nonmyeloablative BMT for B-cell Lymphomas With Post-transplantation Cy and Rituximab
NCT02738866Palbociclib With Fulvestrant for Metastatic Breast Cancer After Treatment With Palbociclib and an Aromatase Inhibitor
NCT03973918Study of Binimetinib With Encorafenib in Adults With Recurrent BRAF V600-Mutated HGG
NCT05025423Phase II Trial of Venetoclax and Rituximab as Initial Therapy in Older Patients With Mantle Cell Lymphoma
NCT00897273Oral HPV Infection in Young Men
NCT00499486Sirolimus in Treating Patients With Advanced Pancreatic Cancer
NCT02048384A Study of Metformin With or Without Rapamycin as Maintenance Therapy After Induction Chemotherapy in Subjects With Pancreatic Cancer
NCT06463249Behavioral Weight Loss for Cancer Survivors in Maryland: A Trial With Adaptive Interventions
NCT02215876Neoadjuvant Doxorubicin/Cyclophosphamide Followed by Eribulin Chemotherapy (ACE) in Operable HER2-negative Breast Cancer
NCT02601014Biomarker-Driven Therapy With Nivolumab and Ipilimumab in Treating Patients With Metastatic Hormone-Resistant Prostate Cancer Expressing AR-V7
NCT00566098Activated White Blood Cells With ASCT for Newly Diagnosed Multiple Myeloma
NCT03711058Study of PI3Kinase Inhibition (Copanlisib) and Anti-PD-1 Antibody Nivolumab in Relapsed/Refractory Solid Tumors With Expansions in Mismatch-repair Proficient (MSS) Colorectal Cancer
NCT01282216Patient-donor Vaccination in the Context of Allogeneic Bone Marrow Transplant With Post-transplant Cyclophosphamide
NCT00093834Vaccine Therapy With or Without Cyclophosphamide and Doxorubicin in Women With Stage IV Breast Cancer
NCT00982449124I-FIAU Imaging in EBV and KSHV Associated Cancers
NCT00470093Interferon Alfa and Interleukin-6 in Treating Patients With Recurrent Multiple Myeloma
NCT00492921High-Dose Cyclophosphamide for Steroid Refractory GVHD
NCT02188563A Comprehensive Smoking Cessation Intervention Duration Radiation for Upper Aerodigestive Cancers
NCT04363164Sequential Testosterone and Enzalutamide Prevents Unfavorable Progression
NCT04131413HPV DNA Vaccine Via Electroporation for HPV16 Positive Cervical Neoplasia
NCT01729260Mebendazole in Newly Diagnosed High-Grade Glioma Patients Receiving Temozolomide
NCT02523924Pilot Study of 18F-DCFPyL PET/CT in the Evaluation of Men With an Elevated PSA Following Radical Prostatectomy
NCT00058123Poly-ICLC in Treating Patients With Recurrent or Progressive Anaplastic Glioma
NCT05716009Tagraxofusp-erzs, an IL-3 Diphtheria Fusion Protein, in Combination With Gemtuzumab Ozogamicin in Patients With Relapsed/Refractory AML
NCT06836648Single Patient Compassionate Use of X-PACT in Salvage Treatment of Prostate Cancer
NCT01666353PET Quantitative Assessments of Solid Tumor Response to Immune Checkpoint Blockade Therapy
NCT03283553Involving Family to Improve Communication in Breast Cancer Care
NCT03153410Pilot Study With CY, Pembrolizumab, GVAX, and IMC-CS4 (LY3022855) in Patients With Borderline Resectable Adenocarcinoma of the Pancreas
NCT02225925Intraoperative Dosimetry for Prostate Brachytherapy Using Fluoroscopy and Ultrasound
NCT05560685SMART-ER: Symptom Monitoring With Patient-reported Outcomes
NCT06014255Trial of Neoadjuvant Enoblituzumab vs SOC in Men With High-Risk Localized Prostate Cancer
NCT01861340Lenalidomide, Dexamethasone and MEDI-551 in Untreated Multiple Myeloma
NCT00287989Erlotinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III, Stage IV, or Recurrent Non-Small Cell Lung Cancer
NCT02396368A Study of Radium-223 in Combination With Tasquinimod in Bone-only Metastatic Castration-Resistant Prostate Cancer
NCT00343447Cyclophosphamide and Rituximab Followed By Vaccine Therapy in Treating Patients With Chronic Lymphocytic Leukemia
NCT01958515Immunologic Responses in HPV-Associated Carcinoma for Patients Receiving Chemoradiation
NCT00002600Combination Chemotherapy, Bone Marrow Transplantation, and Peripheral Stem Cell Transplantation in Treating Patients With Ovarian Epithelial Cancer
NCT00003538Prevention of Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation
NCT02203695Randomized Salvage Radiation Therapy Plus Enzalutamide Post Prostatectomy
NCT02512172A Study of Enhancing Response to MK-3475 in Advanced Colorectal Cancer
NCT03250273A Clinical Trial of Entinostat in Combination With Nivolumab for Patients With Previously Treated Unresectable or Metastatic Cholangiocarcinoma and Pancreatic Adenocarcinoma
NCT01845805Trial to Improve Outcomes in Patients With Resected Pancreatic Cancer (Azacitidine)
NCT05950139Peptide Vaccine To Prevent Acquired Resistance In Patients With Advanced ALK+ NSCLC
NCT02981524Study of GVAX (With CY) and Pembrolizumab in MMR-p Advanced Colorectal Cancer
NCT06210854Assessing Jet Administration of pBI-11 for the Treatment of Patients With HPV16/18+